Skip to content

Clinical trials

Phase 4 Dilatation, Pathologic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dilatation, Pathologic Phase: Phase 4 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20163
20172
20181
20201
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
University of California, San Diego2
Medstar Health Research Institute1
Sheba Medical Center1
Stanford University1
University of California, San Francisco1
University of Pittsburgh1
Virginia Commonwealth University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dilatation, Pathologic10
Pain3
Heart Failure2
Hypertrophy, Left Ventricular2
Heart Failure, Systolic1
Hemorrhage1
Procedural Pain1
Pupil Disorders1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.